Co-immunofluorescence (co-if) was therefore performed to further examine the extent of BTK, SOX2, and CD163 co-expression within individual cells in GBM and a low-grade glioma (Figs 10, 11, S8, and S9). This evidence concerns the gene CD163 and glioma.